Intragastric Acidity Under a 28-Day Omeprazole Treatment
H. G. Dammann, Timothy Walter, Peter Müller, Bernd Simon
Abstract
H. G. Dammann, Timothy Walter, Peter Müller, Bernd Simon
Abstract
Omeprazole effectively reduces gastric acid secretion by an interaction with the gastric H+K+ATPase proton pump in the secretory membrane of the parietal cell. The inhibition is dose dependent and long lasting. Under repeated doses of omeprazole, 30–60 mg/day p.o., over a period of 7–14 days, a reduction of the 24-hour intragastric acidity of between 72% and 99% has been observed (1–3). In one study, the cessation of omeprazole treatment was followed by intragastric hyperacidity (+ 35%) (4).
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Omeprazole effectively reduces gastric acid secretion by an interaction with the gastric H+K+ATPase proton pump in the secretory membrane of the parietal cell. The inhibition is dose dependent and long lasting. Under repeated doses of omeprazole, 30–60 mg/day p.o., over a period of 7–14 days, a reduction of the 24-hour intragastric acidity of between 72% and 99% has been observed (1–3). In one study, the cessation of omeprazole treatment was followed by intragastric hyperacidity (+ 35%) (4).
Key concepts: Omeprazole, Proton-pump inhibitor, Parietal cell, Gastric acid, Gastric secretion, Secretion, Internal medicine, Chemistry